← Insider buys
OLMA

Olema Pharmaceuticals, Inc. · Healthcare

CH. Discov., Non-clin DEV OFF David C. Myles sold $3.1M of Olema Pharmaceuticals, Inc.

Sold$3,107,229
$28.25Price
110,000Shares
−14%Stake

What OLMA did after the filing

Filed Jan 14Copier in Jan 15
The stock from Thu, Jan 15 open, $28.30
−15.1%
S&P 500, same days
−1.2%

Measured over 30 trading days, to the Mar 2 close.

Traded Mon, Jan 12. Filed Wed, Jan 14, 4:30 PM ET, after the close. Returns use the Jan 15 open and the Mar 2 close. Not investment advice.